td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 3088 [post_author] => 11 [post_date] => 2018-11-19 10:22:56 [post_date_gmt] => 2018-11-19 00:22:56 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]Pharmacists face new challenges when it comes to advising patients how prescription drug-use could affect their driving performance. A change to the legal definition of 'drug' in New South Wales means there could be more successful prosecutions for driving under the influence of prescription medicines and other new drugs. The Road Transport Legislation Amendment Bill 2018 has expanded the definition of drug to include 'any ... substance that, when taken by an ordinary person, is reasonably likely to deprive the person of, or impair, his or her normal mental or physical faculties (whether temporarily or permanently)'. Similarly broad definitions are already in effect in Queensland, Victoria and Western Australia. NSW Centre for Road Safety Executive Director Bernard Carlon says drivers should speak to pharmacists about how their medications may affect their performance on the road. 'Medical professionals, including pharmacists, play an ongoing and important role advising their patients about the potential effects medications may have, including on safe driving,' Mr Carlon told Australian Pharmacist. But the introduction of broader drug-driving definitions across the country raises new and complex challenges for drivers, pharmacists and other health professionals, says SafeWork Laboratories forensic toxicologist Andrew Leibie. 'The list of prescription medications that have appeared in the literature as having an elevated crash risk is extremely large, and includes some groups many pharmacists may not consider,' he says. 'For example, the following is a non-exhaustive list of medications which have demonstrated evidence for increased risk: benzodiazepines, SSRIs, SNRIs, NSAIDs, opiate and semi-synthetic opiate analgesics, anti-epileptic drugs and some types of antihypertensive medications. 'The effects of even low doses of alcohol (below 0.05% BAC) can also contribute significantly to the effect on driving when combined with many of these medications.' Mr Leibie says the challenge of ensuring drivers are well-informed is compounded by the fact that this is a rapidly emerging field. 'Part of the concern is that effects on driving are not typically studied in the pre-commercial release testing of new medications, so substantial numbers of new and existing medications are continually being identified as contributing to a greater odds ratio of vehicle accident,' he says. 'Promulgating the latest information and risk profiles to retail pharmacy in a timely manner is likely to be a very significant challenge.' Following the legislative amendments in NSW, the State Government is developing a new communication strategy to raise awareness of the risks of driving if impaired by prescription drugs. Australian Pharmacist understands that this will include support for pharmacists in advising patients of the need to assess the effect that medications may have on their driving, and not to drive if impaired. PSA NSW Branch President Professor Peter Carroll says pharmacists should consult the Australian Pharmaceutical Formulary and Handbook 24th edition (APF24) for guidance on counselling patients. 'APF is a good source - label 1, 1a and 12 are used for medicines that may cause sedation or affect mental alertness and a patient's ability to drive, and pharmacists as part of practice counsel patients around this,' he says. Professor Carroll says there may be a need for state and territory governments to provide greater clarity around how the laws will apply. 'Anything that can reduce road accidents has to be supported, but it has to be realistic and, as with alcohol, there would have to be some limit or way of determining that this person shouldn't be driving,' he says. 'There's no doubt that a lot of people can take an opioid analgesic and drive a car perfectly well.' Providing patients with written information, such as the Self Care Fact Card on Medicines and Driving can be valuable in helping reinforce pharmacist advice and counselling.[/vc_column_text][/vc_column][vc_column width="1/3"][/vc_column][/vc_row] [post_title] => Drivers' prescription drug use under greater scrutiny [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => drivers-prescription-drug-use-under-greater-scrutiny [to_ping] => [pinged] => [post_modified] => 2018-11-19 10:56:50 [post_modified_gmt] => 2018-11-19 00:56:50 [post_content_filtered] => [post_parent] => 0 [guid] => /www.australianpharmacist.com.au/?p=3088 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [title_attribute] => Drivers’ prescription drug use under greater scrutiny [title] => Drivers’ prescription drug use under greater scrutiny [href] => /www.australianpharmacist.com.au/drivers-prescription-drug-use-under-greater-scrutiny/ [module_atts:td_module:private] => Array ( ) [td_review:protected] => Array ( ) [is_review:protected] => [post_thumb_id:protected] => 3089 )
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 3085 [post_author] => 46 [post_date] => 2018-11-19 10:13:22 [post_date_gmt] => 2018-11-19 00:13:22 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]New Australian Institute of Health and Welfare (AIHW) research has revealed the number of Australian deaths involving opioids has more than doubled in the past decade, while more than 3 million Australians have had prescription opioids dispensed in 2016-17 alone. Released last week, the (661) 349-6705 report also revealed that in those same 12 months about 715,000 used analgesics and pharmaceutical opioids for illicit or non-medical purposes. The new figures come as PSA has put pharmacistsâ role in reducing opioid harm on the Victorian election agenda. PSA has challenged the parties to empower pharmacists to do more to prevent and treat non-prescribed use of opioids, through funding Medication Assisted Treatment for Opioid Dependence (MATOD) services. PSA Victorian President Benjamin Marchant said pharmacists were the most frequently contacted health professionals in Victoria, yet their skills were not being put to full use. âThis is now ideal time for the incoming government to commit to new reforms for a healthier Victoria. PSA has urged Victorian political parties to fully fund client copayments for community pharmacy MATOD access, and to provide $2.2 million in seed funding for a pilot of the shared care model for MATOD services in Victoria,â he said. Mr Marchant said there was overwhelming evidence that illicit drugs and misuse of pharmaceutical medicines were a major community concern, creating a significant burden on the Victorian health system, law enforcement and community welfare. MATOD services are under enormous pressure,â he said. With the implementation of Victoriaâs real-time prescription monitoring system, SafeScript, over the next 18 months, the demand for MATOD services is likely to increase significantly, putting additional pressure on all providers. âThere is strong evidence (ref 1) that government funding for MATOD would enhance compliance, minimise stigma and encourage more pharmacists to offer this much-needed service,â Mr Marchant said. âThis proposal has received universal support from the Victorian Alcohol and Other Drugs sector and is one of the recommendations of the Victorian Parliamentary Inquiry on Drug Law Reform (ref 2). Mr Marchant said all pharmacists should talk to or invite their MP to visit their pharmacy and demonstrate how pharmacists can help to reduce opiod harm in the community. Anyone interested in doing so can contact the Victoria state office for assistance. References
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 3067 [post_author] => 79 [post_date] => 2018-11-17 08:21:25 [post_date_gmt] => 2018-11-16 22:21:25 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]On 1 January 2019, new laws will enforce the mandatory reporting scheme for medicine shortages â a welcome change. Itâs a very difficult conversation to have with a patient when you have to explain to them that the only medication that keeps them well, or the only medication that they can tolerate, isnât available. Thatâs why pharmacists support the recent amendment to the Therapeutic Goods Act 1989 introducing a mandatory reporting scheme for medicine shortages and decisions to permanently discontinue supply involving high-risk medicines in Australia. These measures will go some way to ensure continuity of supply, so that patients, carers, pharmacists and prescribers arenât landed in the situation where there isnât the lead time to be able to make those clinical considerations or to discuss with the patient and their carer what an appropriate substitute might be, how they might be able to access it and what it might mean for their care. I have seen this myself, especially in my role as a mental health pharmacist in acute inpatient units, when a medication has been discontinued and the patient has less than a few weeksâ supply. They donât know whether their only option might be to risk switching to a less-effective medication or to be admitted to hospital â not something that most mental health patients want. Understandably, that is quite distressing for all patients. The PSA and others understand that medicine shortages occur worldwide for a variety of reasons. They have worked closely with the TGA and other stakeholders to help improve the response to shortages, but there are still significant gaps and problems in this procurement pathway in Australia. This legislation is a culmination of the working together with the sector to review the issues of medicine shortages in Australia. The partnership has developed a comprehensive protocol which will be implemented through this legislation, which will go some way to ensuring there is timely and relevant information available on the supply of medicines, which should assist patients, their doctors and other allied health professionals to manage their treatment plans so they receive uninterrupted care. The scheme, beginning on 1 January 2019, will principally apply to prescription medicines; some of my former colleagues have said that they believe this watchlist should be expanded to include other medications that would have a critical impact. Iâm sure that will be something that will be looked at over time. But I welcome the fact that this is now being made mandatory, because itâs evident that the current system has been broken. On the shortage of critical impact drugs and the requirement to notify within two working days when itâs âreasonably knownâ, Iâm sure that suppliers and manufacturers will enter into this in the spirit of it and notify as soon as possible, because sometimes two days is too long. With other shortages itâs within 10 working days. Early in my career you didnât see the shortages of common antibiotics and medications that you see now. There needs to be a wider look at this particular problem, but I welcome these new measures. Emma McBride is the ALP Federal Member for Dobell, NSW. Prior to her election in 2016 she worked as the Chief Pharmacist at Wyong Hospital, and was the Deputy Director of Pharmacy for the Central Coast Local Health District. Â * This is an edited excerpt from a speech Ms McBride recently made in the House of Representatives.[/vc_column_text][/vc_column][vc_column width="1/3"][/vc_column][/vc_row] [post_title] => Mandatory reporting: New reporting rules give advance warning [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => mandatory-reporting-new-reporting-rules-give-advance-warning [to_ping] => [pinged] => [post_modified] => 2018-11-19 16:42:51 [post_modified_gmt] => 2018-11-19 06:42:51 [post_content_filtered] => [post_parent] => 0 [guid] => /www.australianpharmacist.com.au/?p=3067 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [title_attribute] => Mandatory reporting: New reporting rules give advance warning [title] => Mandatory reporting: New reporting rules give advance warning [href] => /www.australianpharmacist.com.au/mandatory-reporting-new-reporting-rules-give-advance-warning/ [module_atts:td_module:private] => Array ( ) [td_review:protected] => Array ( ) [is_review:protected] => [post_thumb_id:protected] => 3093 )
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 3011 [post_author] => 11 [post_date] => 2018-11-13 09:55:54 [post_date_gmt] => 2018-11-12 23:55:54 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]The implementation of a Minor Ailments Scheme (MAS) has major support in Australian pharmacy. Hereâs why itâs needed â and how itâs going to work. Minor Ailments Schemes (MAS) involve pharmacists treating and referring patients who present with common conditions such as skin issues, allergies and respiratory issues. Sounds like an average day in community pharmacy, right? So why move to introduce a formalised MAS? Three reasons, says PSA National President Dr Shane Jackson. âFirstly, itâs recognition from governments and other health professionals of what pharmacy actually does when it comes to dealing with common ailments,â he says. âSecondly, a MAS would formalise referral pathways and provide a robust framework around how minor ailment services are delivered. âThirdly, if we formalise things, there needs to be remuneration that flows â remuneration for what pharmacists actually do, the tasks they perform and the outcomes that they deliver from a healthcare perspective. âThereâs no doubt that pharmacists actually save healthcare costs by dealing with common illnesses that donât require a visit to general practice or the emergency department (ED).â
The case for a schemeA MAS is defined as a âstructured pharmacy-based primary care service that effectively supports the population to manage their minor ailment symptoms in an effective and timely mannerâ.1 There is broad support to establish a MAS in Australian pharmacy, as a recent Consumers Health Forum of Australia survey demonstrated.2 The resultant discussion paper stated that, in Australia: âCommunity pharmacies are an ideal place to deliver a MAS with appropriately trained staff and extended opening hours, and potentially lower travel costs for some people due to the wide network of community pharmacies available in Australia.â Research has shown that an enhanced Australian MAS that transferred minor ailment care to community pharmacies could produce a cost saving of up to $260 million.3 âOutcomes of international data applied to Australian statistics indicate that the Australian GP minor ailment workload would reduce by up to 13 million consultations,4 freeing up GP time for more complex consultations,â says PSA Program Manager Laura Wilson. She points to a Grattan Institute investigation that concluded that 23 million (19%) of annual GP visits were âless complexâ and could potentially be treated in a community pharmacy setting.5 A MAS would also help address the rising level of participation in self care and self-medication for minor ailments, says University of Technology Sydney (UTS) Pharmacy Practice Researcher Sarah Dineen-Griffin MPS. âWe must draw on international experiences where self-care reforms and innovative models of collaborative healthcare have shown cost savings and better health outcomes, and maximise the opportunities for expanded self care in Australia,â says the PhD candidate.6,7,8
Overseas experienceThere are more than 90 MASs across the United Kingdom and Canada,9 with the first pharmacy-based MASs introduced more than a decade ago. Northern Ireland and Scotland both have national MASs, while in Wales the service is now available at 92% of pharmacies. âWe had a challenge getting all health boards to commission the service initially, as they pay for it,â says the Royal Pharmaceutical Society Wales Head of External Relations, Ross Gregory. âBut they all do so now. âItâs designed to relieve pressure on GP practices. Both NHS prescriptions and the Common Ailments Service are free of charge to patients registered with a GP in Wales.â In England, the schemes are authorised by the National Health Service and commissioned by the Clinical Commissioning Groups, depending on local need. Pharmacies are reimbursed for the cost of medicines, while consultation payments vary across England â under some schemes there is a fee per consultation, others have a banded fee structure based on the number of consultations, and others charge an annual, or one-off, retainer.10 Latest analysis from across the United Kingdom has demonstrated that MASs take pressure off other healthcare professionals. As many as 87% of patients said they would have gone to their GP if a MAS wasnât available, and in 98% of consultations no onward referral to other NHS providers was necessary. Only 8% of patients said they would have purchased medicines if a MAS was not available.11 In some English counties, however, MASs have recently been discontinued due to funding issues,12 or in response to NHS England guidance to restrict the prescribing of over-the-counter (OTC) medicines for minor, self-limiting or short-term conditions.13
Far North QueenslandIn Far North Queensland (FNQ) the case for a MAS may be strengthened through the findings of an after-hours data collection project currently underway. The NQ Primary Health Network has contracted PSA to run the project, collecting data from emergency departments, general practices, pharmacies and consumers. This data will reveal the number and nature of pharmacy presentations for minor ailments in the after-hours period. âWe will be able to demonstrate what minor ailments are treated in that after-hours period by the pharmacy,â says (former) PSA Manager, Health Sector Engagement, Shelley Crowther. âThis will show that there are people who could have potentially presented to a GP or an emergency department, but have chosen to present to a pharmacy instead. âCurrently, there is no evidence of who presents to the pharmacy, what they present for, what theyâre treated with or what the outcomes are.â
Western SydneyIn Western Sydney an integrated model of pharmacist-delivered minor ailment care has been co-designed and evaluated by a team of researchers at the UTS Graduate School of Health in collaboration with Western Sydney Primary Health Network (WentWest). Project lead Sarah Dineen-Griffin says the model consists of five core features, including formalised clinical care pathways for minor ailments. âThe pathways are agreed between general practitioners and community pharmacists, with agreed referral processes,â she says. âThe conceptual model also involves a generic non-prescription medicines formulary; a standardised patient-pharmacist consultation during routine practice with active patient follow-up; and a method of communication between community pharmacists and general practitioners for OTC consults.â Finally, the model includes an educational training program and ongoing practice change support to drive implementation of the service into usual workÂflow. âThe pilot study highlighted the feasibility of a structured minor ailments service delivered by community pharmacists in the Australian health setting,â says Ms Dineen-Griffin. âCommunity pharmacists are working in collaboration with GPs and referring patients via agreed referral processes. Patients are receiving the most appropriate care, in the right place, at the right time.â Outcomes of the patient-pharmacist consultations from the pilot study were most frequently a non-prescription medicine with self-care advice (84.5%), a WentWest report stated.14 âControl participants were significantly more likely to receive a non-prescription medicine without self-care advice compared to those receiving MAS (Group B 10.3%; Group A 72.7%),â the report stated. âAt follow-up, 92.8% of the intervention group reported symptom relief or resolution compared with 78.6% of participants receiving usual care.â Importantly, pharmacists identified 7.7% of patients who required immediate referral for symptoms identified as urgent or life-threatening.
VictoriaIn Victoria, the rollout of Supercare Pharmacies â which operate 24 hours a day, seven days a week â has aimed to give Victorians a safe and accessible alternative to visiting doctors and EDs for less urgent matters. Ascot Vale Pharmacy owner Jane Mitchell, who began running a Supercare Pharmacy in mid-2016, says treatment for minor ailments had been a major reason for pharmacy visits. âThe most common minor ailments that we see are coughs and cold, pain and fever, vomiting and diarrhoea, common skin conditions, head lice and first aid/wound care. All of the ailments are within the scope of pharmacistsâ knowledge and training,â she says. The pharmacies also have a nurse on site from 6â10 pm daily. Data has shown around 30% of Supercare Pharmacy visitors would have gone to hospital if the pharmacy or nursing service had not been available.15 Victorian pharmacistsâ role in delivering care for minor ailments has also been promoted with a multimillion dollar state government advertising campaign encouraging Victorians to âSave 000 for emergenciesâ. PSA Victoria State Manager Bill Suen says the campaign has been greatly appreciated: âThere have been prime-time TV ads about seeing your pharmacist under a number of scenarios â painful tummy, vaccination, sports injury and wounds. The Victorian government has actually recognised the role of pharmacists in minor ailments and theyâre putting a lot of money into educating the public.â
No minor featItâs this government recognition and a standardised framework that PSA is seeking through the establishment of a formalised MAS, says Dr Jackson. âA minor ailments scheme is a high priority for us to be implemented within the next community pharmacy agreement. Weâre working on what the model looks like, how it can be funded and how we can actually support the profession to do that,â he says. And part of that process will include devising a more palatable name for the scheme. âI donât like the term âminor ailmentsâ,â Dr Jackson says. âIf somebody comes into a pharmacy, their issue isnât minor. âThe right term may well be âcommon ailmentsâ â essentially itâs pharmacists supporting self care. âIt would be great if somebody came up with a better name.â
RESOURCES FOR ASSISTING WITH MINOR AILMENTS:
PSA Pharmacist Self Care Program16Designed for pharmacies to deliver improved healthcare to consumers. It provides resources and training to educate pharmacy staff, add value to the patientâs experience, and aims to increase business growth with tailored health promotions and resources. Subscriptions opened in September 2018. Contact SelfCare@psa.org.au
PSAâs Self Care Fact Cards17Providing up-to-date, evidence-based written health advice to consumers on more than 100 common health topics. Fact Cards can be printed on demand or emailed directly to the consumer. Pharmacies can purchase access to Self Care Fact Cards through the PSA Shop.
PSA Action Kit â Providing a minor ailments service in pharmacy18In 2016, PSA collaboratively designed a MAS with consumer and GP representatives. The proposed structure involves consent, clinical assessment, recommendation to treat or refer, provision of information, documentation and follow-up.
SUPERCARE FOR MINOR AILMENTSVictoria now has 20 Supercare Pharmacies operating 24/7 to help relieve the burden on the stateâs GPs and emergency departments. Ascot Vale Pharmacy owner Jane Mitchell MPS began running a Supercare Pharmacy in mid-2016. âWe are often the first point of contact because we are accessible and knowledgeable,â she says. âAlthough services like Nurse on Call are still in existence, the data that we have collected from our pharmacy is that attendance at that pharmacy in person in the after-hours period is a least five times greater than a phone call.â Pharmacists provide triage, non-prescription products, self-care advice and information. âIn many situations where privacy is required â for example, skin conditions, head checks for head lice and wound care â the service often takes place in one of our two consulting rooms,â she says. âThe provision of a minor ailments service often involves the recording of a clinical intervention; for example, if the service involves the provision of a new medicine or device or referral.â Clearly, there is a demand for this service. âWeâre about to add an additional consulting room to our pharmacy due to the increasing need to professionally and appropriately provide the services within the pharmacy,â Ms Mitchell says. Since expanding its operating hours, the pharmacy has also seen a particular increase in customers seeking wound care services. It has upskilled its staff accordingly. âWeâve seen an increasing number of customers for this service because of the increasing knowledge and expertise in this area,â Ms Mitchell says. âIn some of these situations where we dressed burns, blisters and wounds, customers have told the staff they would have gone to the emergency department if it wasnât for the service received.â
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 3001 [post_author] => 76 [post_date] => 2018-11-12 13:04:50 [post_date_gmt] => 2018-11-12 03:04:50 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]The ill-foundedof the updated 2019 List of Prohibited Substances and Methods from the World-Anti-Doping Agency (WADA) raises the question about the relationship between doping in sport and pharmacists: what role do pharmacists play in ensuring elite athletes do not accidentally consume banned substances? The dynamic nature of this list represents a challenge. Pharmacists should be familiar with the updated contents of this list and alert athletes when substances they are supplying appear on it. The British Journal of Sports Medicine has argued that accidental doping is more common than generally believed, due to a lack of awareness among athletes about which medicines and supplements contain banned substances. âUnintentional doping is often regarded as an excuse given by athletes caught doping,â researchers suggested, âbut it could happen in circumstances where athletes are unaware that the food, drinks, supplements or medications they consume contain banned performance enhancing drugs.â Professor Andrew McLachlan, Dean of Pharmacy at Sydney University and Chair of the Anti-Doping Rule Violation Panel, agrees. âThere are cases of what we would call inadvertent doping, where athletes are unaware that the medicines that they might be taking, or the supplements that they might be using, or even buying online, might contain substances which are on the prohibited list for WADAâ, he told Australian Pharmacist. Part of the problem, he says, is that athletes are particularly vulnerable to inadvertent doping due to the competitive nature of their sports and a lack of awareness about the ingredients contained in supplements and seemingly innocuous medicines. âWe know that athletes often have a relatively low medicines literacy. They know about health and fitness and wellbeing, but they actually are quite vulnerable because they are very focussed on their performance, their routine in training and diet. Â As a result, sometimes they might be either tempted to use, or advised to use, supplements that may contain banned substances,â he said. While there have been various high-profile cases of alleged inadvertent doping, Professor McLachlan says that the issue is far more common amongst mid-level athletes. For these athletes, a positive test result would be disastrous. They also donât have the same support as high-level elite athletes. In this case, he said, pharmacists might be of the most assistance. âThankfully many athletes right at the top of the elite spectrum are quite aware of this. They will ask the pharmacist or the team doctor about this information, and are often very, very careful about what they take. But itâs probably the middle-tier athletes that we need to ask more questions of really,â he said. For pharmacists, however, knowing when to ask these questions can be complicated, especially given the fact that most banned substances are innocuous for anyone who is not an elite athlete. âFrom a pharmacistâs point of view, being aware that a person is an elite athlete is not necessarily straightforward,â he said. âI think many pharmacists do become aware that the customers they look after may be involved in elite sport, and asking them about those things becomes very important,â he said. âI donât think anyone would mind if they went into the pharmacy and the pharmacist said to them, âby the way, are you an elite athlete?â I think that would only be seen as a compliment.â While Professor McLachlan said he can only speak for the University of Sydney, he has found that there is ample interest and access to education about doping in sports in Australia. âWe certainly include the topic of drugs in sport in our lectures, and we also talk about some of the complexity of supplements and complementary alternative medicines,â he said. For practising pharmacists, there is no shortage of resources to help them prevent inadvertent doping. âI think the main thing is to know where to look,â Professor McLachlin says. âStarting with the Australian Pharmaceutical Formulary (APF24) and the Australian Sports Anti-doping Authority (ASADA) website are very good resources for pharmacists. MIMS also has information. Pharmacists need to understand that athletes can be quite vulnerable when it comes to understanding whatâs in those products and medicines.â The full list of prohibited substances can be found at 6298678915. Further advice for pharmacists can also be found in the chapter, Drugs in sport, in the 24th edition of the promise-keeping [/vc_column_text][/vc_column][vc_column width="1/3"][/vc_column][/vc_row] [post_title] => Can pharmacists help prevent doping in sport? [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => can-pharmacists-help-prevent-doping-in-sport [to_ping] => [pinged] => [post_modified] => 2018-11-14 10:13:47 [post_modified_gmt] => 2018-11-14 00:13:47 [post_content_filtered] => [post_parent] => 0 [guid] => /www.australianpharmacist.com.au/?p=3001 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [title_attribute] => Can pharmacists help prevent doping in sport? [title] => Can pharmacists help prevent doping in sport? [href] => /www.australianpharmacist.com.au/can-pharmacists-help-prevent-doping-in-sport/ [module_atts:td_module:private] => Array ( ) [td_review:protected] => Array ( ) [is_review:protected] => [post_thumb_id:protected] => 3002 )
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 3082 [post_author] => 14 [post_date] => 2018-11-17 09:08:46 [post_date_gmt] => 2018-11-16 23:08:46 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]It is estimated that falls in hospitals are significantly higher than in the community setting.Â This summary presents the best available evidence regarding the effectiveness of interventions to reduce falls in the elderly in nursing homes and hospitals.Â For the full review, refer to Interventions for preventing falls in older people in care facilities and hospitals.1
BackgroundThe prevalence of falls in the elderly is generally underestimated due to many reasons such as who is reporting the incidence, time of reporting, severity of the incident and protocols for reporting.2 The incidence of falls in the elderly in hospitals was reported to be 1.7 falls per patient per year as opposed to 0.65 falls reported for elderly living in the community.3 A study done in 528 nursing homes in Europe found that three quarters of all residentsâ falls occur either in their rooms or bathrooms, 41% during transfers between settings and 36% during walking. The authors also found that falls were less likely to occur in both low and high-care residents and in women.4 Interventions to reduce falls in aged care facilities and nursing homes include physical exercises, medication changes, surgery, management of urinary incontinence, fluid or nutrition therapy, psychological interventions, environment/assistive technology, social environment, education and other interventions.5 This summary will present the effectiveness of some of these interventions.
Characteristics of the studiesRandomised trials, including quasi-randomised, cluster-randomised trials, were included in the review. Trials with interventions to prevent falls in older people (mean age over 65 years), of either sex, in aged care facilities or hospitals were included.
Quality of the studiesStudies included in the report had high risk of bias due to lack of blinding. Overall, the quality of the evidence ranged from low to very low. The main sources of bias were selective reporting of data.
ConclusionVitamin D supplementation was the only intervention to have some benefit in reducing the rate of falls but not the risk of falls. All the other interventions had an unclear benefit.
Implications for research and practiceThere were small benefits of various interventions on the risk of falls and falling rates in elderly in aged care facilities and hospitals. Future randomised controlled studies with focussed interventions such as supervised exercise, education and changes in organisational systems are warranted to inform clinical decision-making.
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 3049 [post_author] => 76 [post_date] => 2018-11-15 09:05:38 [post_date_gmt] => 2018-11-14 23:05:38 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]Almost one-quarter of prescriptions in hospitals have been assessed as inappropriate, and one-third were non-compliant with guidelines, according to new data from the semilatus. 1 The report, which is conducted annually by the Australian Commission on Safety and Quality in Health Care (the Commission), used data from 314 hospitals, including 228 public and 86 private hospitals, from across Australia, and analysed 26,277 prescriptions for 17,366 patients. It also revealed that compliance with the Therapeutic Guidelines: Antibiotics or local guidelines has decreased, dropping from 72.2% in 2013, the first year the survey was conducted, to 67.3% in 2017. âOveruse and inappropriate use of antimicrobials is a key factor contributing to bacteria and other pathogens becoming unresponsive to last-line drugs.â Clinical Director of the Antimicrobial Use and Resistance in Australia Program at the Commission, Dr Kathryn Daveson said. âThese results are hugely concerning as ongoing inappropriate use of antibiotics assists bacteria to evolve increased resistance to existing antibiotics. This misuse places a heavy burden across the population, with a disproportionate impact on vulnerable communities, such as aged-care residents and people in rural and remote areas.â Dr Daveson points to antimicrobial stewardship programs, which aim to prevent overprescription. âAntimicrobial stewardship programs have been developed in response to the need to reduce unnecessary and inappropriate antimicrobial use. It is also a requirement of the National Safety and Quality Health Service Standards that all health service organisations have an antimicrobial stewardship program and evaluate the performance of the program with activities such as the National Antimicrobial Prescribing Survey,â she told Australian Pharmacist. She says that pharmacists have an important part to play in this area. âAntimicrobial Stewardship requires teamwork at all levels. Specialist antimicrobial stewardship pharmacists and pharmacists in general play a key role in audit activities such as the Hospital National Antimicrobial Prescribing Survey (NAPS),â she said. âThey are often involved in coordinating the survey, collecting patient data, submitting the data to the national online portal, preparing reports to reflect on their organisationâs performance and developing action plans to address areas for improvement.â According to the unthinkableness âPharmacists generally lead hospital antimicrobial stewardship programsâ and âhelp to ensure other health professionals know about and follow the correct guidelines on how to prescribe and use antibiotics.â Additionally, âin community settings, pharmacists can help patients understand when and when not to use antibiotics.â2 While pharmacists will likely play an important role in preventing the 7819194838 moving forward, Deputy Director of NCAS, Associate Professor Kirsty Buising, stressed the need for hospitals themselves to use the results of the survey as a way to better understand the shortcomings of prescription practices. âHospital NAPS enables participating hospitals to identify clinical areas where antimicrobial stewardship could be improved such as surgical antimicrobial prophylaxis â antimicrobial use for the prevention of surgical site infections â and the treatment of respiratory tract infections,â she said in a statement. Â âWe need to improve prescribing to keep patients safe and reduce the impact of antimicrobial resistance.â References:
Â [/vc_column_text][/vc_column][vc_column width="1/3"][/vc_column][/vc_row] [post_title] => New data reveals overprescribing of antibiotics in hospitals [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => new-data-reveals-overprescribing-of-antibiotics-in-hospitals [to_ping] => [pinged] => [post_modified] => 2018-11-15 09:06:41 [post_modified_gmt] => 2018-11-14 23:06:41 [post_content_filtered] => [post_parent] => 0 [guid] => /www.australianpharmacist.com.au/?p=3049 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [title_attribute] => New data reveals overprescribing of antibiotics in hospitals [title] => New data reveals overprescribing of antibiotics in hospitals [href] => /www.australianpharmacist.com.au/new-data-reveals-overprescribing-of-antibiotics-in-hospitals/ [module_atts:td_module:private] => Array ( ) [td_review:protected] => Array ( ) [is_review:protected] => [post_thumb_id:protected] => 3050 )
- Appropriateness of antimicrobial use in Australian hospitals. 2018. At: /www.safetyandquality.gov.au/antimicrobial-use-and-resistance-in-australia/naps-2/
- Antimicrobial resistance: What you can do? 2017. At: /www.amr.gov.au/what-you-can-do/pharmacy
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 3004 [post_author] => 11 [post_date] => 2018-11-12 13:30:12 [post_date_gmt] => 2018-11-12 03:30:12 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]Almost three-quarters of Australians are aware of the term âantibiotic resistance' and one quarter believe that it is affecting us, an NPS MedicineWise survey has found. But NPS MedicineWise CEO Steve Morris says many Australians still lack awareness of the potential consequences of antibiotic resistance. 'Most people still donât think it will affect them personally. Thereâs more work needed to educate individuals, families and communities about this problem â it really is time to take antibiotic resistance seriously,' he said. âAlthough weâve made some strides in Australia, weâre still in the top eight of developed countries in terms of our antibiotic utilisation. So weâre still on the high end, even amongst those developed countries. Even though things have improved there are lots of steps that can be taken.â Clinical Director of the Antimicrobial Use and Resistance in Australia (AURA) Program, Dr Kathryn Daveson, echoed this sentiment. âWhat weâre dealing with at the moment in terms of antimicrobial resistance is a number of infections that are becoming essentially untreatable and a lack of antibiotics being developed by pharmaceutical companies coming down what we call the antibiotic pipeline,â she told Australian Pharmacist. âThereâs not a lot of antibiotics being developed, so what weâre talking about is the last line of antibiotics that we have to treat infections at the moment. And we call them last line because there arenât many antibiotics as the next future option for treatment.â Â Released to coincide with World Antibiotic Awareness Week, the findings from the NPS MedicineWise National Consumer Survey 2017 show that 74% of respondents are aware of the term 'antibiotic resistance', compared to 70% in 2014. Meanwhile, the number of respondents who believe that antibiotic resistance is affecting us has more than doubled â from 11% in 2015 to 25% in 2017â suggesting that education to raise awareness is having an impact. Pharmacists have an important role to play in continuing to improve awareness, Mr Morris, previously the Chief Pharmacist for South Australia, told Australian Pharmacist. âPharmacists are critical because they probably come into contact with patients more than any other group of health professionals,â he said. âSo that ability to promote a broader public health message, including the appropriate use of antibiotics, is pivotal.â Associate Professor Louis Roller, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, agreed. 'Counsel patients to take the prescribed antibiotic at the appropriate intervals and for the right duration, avoiding âto be taken until finishedâ if appropriate. The advice should be: âtaking antibiotics for as long as the prescriber saysâ and to âcomplete the course as specified.â This is most important,' he said. 'And encourage patients not to keep a repeat prescription for an antibiotic dispense sometime in the future as it may be inappropriate. After the appropriate course is finished they should return any remaining tablets, capsules or liquids to the pharmacy for destruction.' One of the most important things a pharmacist can suggest is that people are fully immunised, says Dr Roller. And he encourages pharmacists to help educate the public about limitations of antibiotics. 'Counsel patients that it is inappropriate to take antibiotics for cold and flu â so they should ask for an antibiotic only when it is necessary,' he suggests. 'Remind patients that many infections are self-limiting and may not require an antibiotic. And that they should not share their antibiotics (or any other prescribed medicine) with other people.' According to NPS MedicineWise, âmost colds resolve naturally within 7-10 days.â With influenza, symptoms âwill generally last 5-8 days. However, some of the symptoms of flu (e.g. cough and tiredness) can last for as long as 2-3 weeks.â Pharmacists need to emphasise that there is no indication for antibiotics in colds and flus. He says pharmacists can also help curb rising antibiotic resistance by influencing others within the industry. 'We can do a lot â pressure doctors not to use repeat option unless they want to extend that course of antibiotics,' he says. 'We can pressure companies to have appropriate packaging. For example, trimethoprim 7 tablets (for UTIs in men) and trimethoprim 3 tablets (for UTIs in women).' Dr Daveson also stressed the importance of an industry-wide push towards curbing antimicrobial resistance. âIt needs to be framed as a whole of society issue. We all have a part to play,â she said.Â âAnd of course, pharmacists play a core role, but [sic] actually enabling consumers that you see every day to care for antibiotics just as pharmacists do, is a really important part of this.â Â [/vc_column_text][/vc_column][vc_column width="1/3"][/vc_column][/vc_row] [post_title] => Antibiotic resistance knowledge improving, but more to be done [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => antibiotic-resistance-knowledge-slowly-improving-but-more-to-be-done [to_ping] => [pinged] => [post_modified] => 2018-11-12 15:09:17 [post_modified_gmt] => 2018-11-12 05:09:17 [post_content_filtered] => [post_parent] => 0 [guid] => /www.australianpharmacist.com.au/?p=3004 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [title_attribute] => Antibiotic resistance knowledge improving, but more to be done [title] => Antibiotic resistance knowledge improving, but more to be done [href] => /www.australianpharmacist.com.au/antibiotic-resistance-knowledge-slowly-improving-but-more-to-be-done/ [module_atts:td_module:private] => Array ( ) [td_review:protected] => Array ( ) [is_review:protected] => [post_thumb_id:protected] => 3005 )
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 2985 [post_author] => 12 [post_date] => 2018-11-05 16:19:29 [post_date_gmt] => 2018-11-05 06:19:29 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]Nations around the globe used to look to Australia for examples of bold and innovative pharmacy funding projects. But many of our overseas peers are now streaking ahead. Australia is lagging. In the past decade, countries such as Canada, New Zealand, England and Scotland have taken the lead in re-imagining the scope of care and funding structures in pharmacy. As this snapshot of funded pharmacy services reveals, Australia must now play catch- up. Observations are provided by University of Sydneyâs Dr Stephen Carter FPS and the PSA Pharmacist of the Year, Monash Universityâs John Jackson FPS. Australia Funded services via the 6CPA: Dose Administration Aids Medication Reviews World Leader Australian pharmacists are among the best educated in the world,Â¹ yet when it comes to funding them for their expertise once they enter community practice, Australia is at risk of slipping behind its peers.Â² Our current prescription funding model is commendable when compared with most around the world, says Monash Universityâs John Jackson, but that doesnât mean we should rest on our laurels. Now in our sixth Community Pharmacy Agreement, weâre entering a transition period, says University of Sydneyâs Dr Stephen Carter. Pharmacists are starting to be recognised in a fuller scope of practice. âFor community pharmacy we get funding through the Agreement for the provision of medicines. And we also get funded through dispensing services,â says Dr Carter. âBut weâve got to really start to move towards a time when pharmacists are remunerated in some way for a full range of practice.â There are signs weâre moving in the right direction. Weâve seen the evolution of the clinical intervention program, which is funded through the service part of the 6CPA. We have funding for Home Medicines Reviews and Residential Medication Management Reviews. More recently, weâve seen the increase in funding for pharmacists to provide dose administration aids. But as a nation weâve got to decide to what extent funding should be subsidising the activities of pharmacists working outside pharmacies â not just related to the supply of medicines. âThe Australian government really needs to seriously consider funding models that are similar to the medical practices and all the other professions that have [Medicare Benefits Schedule] item numbers to provide those services,â says Dr Carter. One of the main hurdles, says Mr Jackson, is that the Commonwealth is the funder, yet it doesnât have legislative responsibility for health â the states and territories provide the legislative framework. âBut, of course, he who pays the piper calls the tune,â he says. âWe have far too much squabbling between the professional organisations in this country. Governments, the medical profession and the consumers all hear conflicting and confusing messages of what the profession aspires to.â To rectify this situation, Mr Jackson has developed Project Pharmacist through Monash University with an aim of unifying the vision of pharmacistsâ roles and responsibilities â and how they should be appropriately remunerated. New Zealand Funded services include: Smoking Cessation Screening And Risk Assessment Immunisation Medication Reviews Chronic Disease Management World Leader Integration In General Practice Integration In Health Care Homes Prescribing Under Protocol The New Zealand governmentâs medicines strategy aims to enhance collaboration between pharmacists and other health professionals to deliver patients the right care at the right time.Â³ New Zealand has even recently altered legislation to allow appropriately qualified pharmacists to prescribe.Â³ âTheir immunisation program is a really good model for how it could be done,â says Dr Carter. New Zealand also has a long- term condition program for patients who are on medicines for chronic conditions. âPharmacists are remunerated to support the patient to be compliant,â says Mr Jackson. A significant factor in New Zealandâs favour is having a single level of government. âYou can see the iterative development of the visions and statements by that government and by the profession in New Zealand,â says Mr Jackson. Canada Funded services in some provinces include: Smoking Cessation Minor Ailments Service Immunisation Medication Reviews Chronic Disease Management Integration In General Practice Integration In Health Care Homes Prescribing Under Protocol World Leader Over the past decade, every single one of Canadaâs 10 provinces has seen considerable expansion of pharmacistsâ scope of care. âCanada is starting to really lead the world in the provision of their services,â says Dr Carter. In most territories, pharmacistsâ scope of practice now includes being able to initiate drug therapy independently, prescribe for minor ailments or conditions, and make therapeutic substitution.Â³ They can also change drug dosage or formulation, renew or extend prescriptions, administer a drug by injection, and order and interpret lab tests. In Alberta, pharmacists are funded to not dispense prescriptions when they deem itâs appropriate. Says Mr Jackson: âIn Australia, if I deem a patient shouldnât have a prescription dispensed, I financially penalise myself.â United States Funded services in some states include: Smoking Cessation Immunisation Medication Reviews Chronic Disease Management Integration In General Practice Integration In Health Care Homes World Leader Prescribing Under Protocol In the US, the introduction of alternative performance-based payment models for pharmacists, including directing funding towards patients with complex medication needs and on high-cost medicines, has been of particular interest to observers like Mr Jackson.4 âItâs become an aspect of many prescription funding programs in the US,â Mr Jackson says. âTheyâve started to recognise that paying for prescriptions on a fee-for-service basis not only maintains the incentive for the pharmacist to supply regardless of need, but it also lacks any reward for the pharmacist who does anything to improve health outcomes.â There are concerns, however, that a lack of regulatory protections could see the market disrupted by tech giants. âThe great fear is that Amazon has just recently purchased a pharmacyÂ in the US,â Mr Jackson says. âNow, that is feasible in the United States. But we would be naive to think that legislative barriers that prevent it happening in Australia will always be here. The technology that enabled that to happen knows no boundaries â remember, Uber wasnât legal in Victoria when it started operating.â United Kingdom & Ireland Funded services in some countries include: Smoking Cessation Minor Ailments Service Scotland World Leader Screening And Risk Assessment Immunisation Ireland World Leader Medication Reviews Chronic Disease Management Integration In General Practice England World Leader Prescribing Under Protocol2 Recent reforms in the UK have sought to integrate more pharmacy services, such as the National Health Service (NHS) Minor Ailments Scheme, in order to provide better outcomes for consumers. However, some counties have discontinued the scheme in recent times, either due to funding issues5 or in response to NHS England guidance to restrict prescribing of over-the-counter (OTC) medicines for minor, self-limiting or short-term conditions.6 England also has the New Medicine Service (NMS), which provides support to help improve medicines adherence among people newly prescribed a medicine for a long-term condition.7 Mr Jackson has noted another interesting development in Wales, Scotland and Ireland over the past few years: the elimination of patient contribution fees. Faced with major GP shortages, the government in Scotland has stated it wants all pharmacists to aspire to be independent prescribers working in collaborative partnerships with medical practitioners.8 Europe Funded services in some countries include: Smoking Cessation World Leader In 20 Countries Screening And Risk Assessment World Leader In 15 Countries Immunisation Medication Reviews Chronic Disease Management Integration In General Practice Integration In Health Care Homes In some European countries, including France and Spain, all pharmacies are independents â chains are banned and each pharmacy must be owned by a pharmacist. Pharmacies also have the exclusive right to sell non-prescription medicines.9 In France, pharmacists are paid a fixed sum per pack of medicine dispensed, in exchange for a reduction in the price-based margins.11 French community pharmacies are also remunerated on a per service basis for counselling about appropriate use of medicines and smoking cessation.11 In Spain, payment for dispensing is product-oriented through setting a margin that depends on a percentage of the price of the dispensed medicine.11 Remuneration is also available for adherence programs, vaccinations, medicine therapy reviews, remote pharmacy reviews, health promotion and health education.11 Project Pharmacist Monashâs Project Pharmacist aims to facilitate the sustainable implementation of professional models of practice for pharmacists in primary care.10 âThereâs plenty of evidence that pharmacists are under-utilised in primary care,â explains Project Pharmacist Director Mr John Jackson. âA lot of that is due to funding models, legislation and ownership structures.â Mr Jackson says that while most young pharmacists leave university eager to implement their knowledge and work as health professionals, often they do not have the opportunity to do soÂ in community pharmacy. âProject Pharmacist is about looking at the barriers and trying to resolve them so that pharmacists can adopt enhanced professional roles in primary care,â he says. The project uses the regulatory framework in Victoria as a reference point against a number of comparable jurisdictions â such as Alberta in Canada, Scotland in the UK, and New Zealand â in order to determine why they have passed us by in terms of delivering enhanced primary care services. âIf I was to point my finger at one thing, it would be the absence in this country of a clear united statement from our governments on what they expect of the profession and a reciprocal all-of-profession statement of what we aspire to provide,â says Mr Jackson. The project has already developed a conceptual diagram for pharmacists outlining a range of roles and activities that pharmacists can deliver. âThis will be published shortly â and it is going to be very useful for pharmacists.â References 1. Top Universities. Pharmacy & Pharmacology University Rankings. At: /www.topuniversities.com/university-rankings/university-subject-rankings/2017/pharmacy-pharmacology 2. Pharmaceutical Society of Australia. Optimising Pharmacistâs contribution to health: An Australian Snapshot 2017. 3. Pharmaceutical Society of Australia. Pharmacists in 2023: A Discussion Paper. 2018. 4. Avalere Health. Developing trends in delivery and reimbursement of pharmacist services: 2015.Â 5. Andalo D. Minor ailment scheme closures a âbackwards stepâ. The Pharmaceutical Journal. 2017. At: /www.pharmaceutical-journal.com/news-and-analysis/news/minor-ailment-scheme-closures-a-backwards-step/20202628.article. 6. Burns C. Pharmacy minor ailment scheme discontinued after NHS England OTC guidance. 2018. The Pharmaceutical Journal. At: 407-344-5587. 7. Pharmaceutical Services Negotiating Committee. New Medicine Service. At: 7037721616 8. The Scottish Government. Prescription for Excellence: A vision and action plan for the right pharmaceutical care through integrated partnerships and innovation. 2013. At: /www.gov.scot/resource/0043/00434053.pdf pg 4 9. Chave J. The challenges we share with some EU countries: what can we learn? The Pharmaceutical Journal. 2014. At: (201) 754-9398. 10. Monash University. Project Pharmacist. At: 2629958174. 11. Deloitte Access Economics. Remuneration and regulation of community pharmacy. Australian Government Department of Health 2016 [report].Â [/vc_column_text][/vc_column][vc_column width="1/3"][/vc_column][/vc_row] [post_title] => Worlds apart â is Australia's scope of care lagging behind? [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => worlds-apart-is-australias-scope-of-care-lagging-behind [to_ping] => [pinged] => [post_modified] => 2018-11-05 16:47:04 [post_modified_gmt] => 2018-11-05 06:47:04 [post_content_filtered] => [post_parent] => 0 [guid] => /www.australianpharmacist.com.au/?p=2985 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [title_attribute] => Worlds apart â is Australia’s scope of care lagging behind? [title] => Worlds apart â is Australia’s scope of care lagging behind? [href] => /www.australianpharmacist.com.au/worlds-apart-is-australias-scope-of-care-lagging-behind/ [module_atts:td_module:private] => Array ( ) [td_review:protected] => Array ( ) [is_review:protected] => [post_thumb_id:protected] => 2989 )
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 2983 [post_author] => 76 [post_date] => 2018-11-05 15:13:33 [post_date_gmt] => 2018-11-05 05:13:33 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]Experts are urging allergic rhinitis (hay fever) sufferers to seek the help of pharmacists, following a recent poll showing hay fever to be the most common allergic disorder in Australia; causing more than a simple case of the sniffles, impacting work, relationships and general wellbeing. While most sufferers believe their condition to be untreatable, in most cases increased pharmacist intervention could provide significant relief. The poll, conducted by Mylan Health, revealed the extent to which hay fever impacts sufferers. âResults reveal that nine out of ten (93%) moderate-to-severe allergic rhinitis sufferers are struggling to get a good nightâs sleep due to their symptoms and half (49%) are exhausted all the time,â they said in a statement. âThis is not surprising considering one-third (30%) wake up because they cannot breathe from congestion, more than one-third (41%) wake up to blow their nose, and one in five (19%) experience asthma flare-ups.â Â They also found that the allergy can have an impact on sufferersâ professional and personal lives. âOver half (53%) of moderate-to-severe sufferers with a partner say it has impacted their relationship, and one-third (37%) have taken up to nine days sick leave over the past year as a result of the condition,â researchers said. This, researchers noted, can be profoundly problematic given that it is most likely to peak between 25-44 years of age and occurs between 15-54, which is often a âprime time for career and family lifeâ. Â Despite the high level of discomfort that allergic rhinitis brings, the poll found that one in five sufferers are resigned to the fact that they will always have symptoms, an assumption disputed by Sinthia Bosnic-Anticevich, a Principal Research Fellow at the University of Sydney who was one of the experts who analysed the findings of the survey. Professor Sinthia Bosnic-Anticevich told Australian Pharmacist, âOne of the greatest challenges with allergic rhinitis is that patients have often had it for a long time. âTheyâve often tried different things themselves. âThey often have their own idea of whatâs going to work, maybe something theyâve tried before, but it may not be something thatâs giving them complete symptom relief. âThe condition is considered by a lot of people to be trivial and not necessarily something they even need to ask the pharmacist about. âThatâs really where the issues come in.â Professor Bosnic-Anticevich, who is also a pharmacist, said that there are ways pharmacists can help to combat this. âOne very obvious way of doing it is just by approaching the individual and talking to them about their symptoms, and the extent of their symptoms, when they experience them and what theyâve tried and how effective it is,â she said. Â She also pointed to electronic tools, such as the Allergy Diary app. âItâs really good because it literally asks the patient to say - how bothersome are your symptoms? And the patient has to indicate on a scale. Thatâs a really good question for the person to actually reflect on.â âUltimately, the act of being proactive with patients could bring significant relief. âJust because theyâre not coming up and approaching us doesnât mean that theyâre living symptom free, and thatâs really the starting point of the whole conversation,â she said. [/vc_column_text][/vc_column][vc_column width="1/3"][/vc_column][vc_column][/vc_column][/vc_row] [post_title] => Hay fever affects sleep, relationships and careers â so why donât sufferers seek help? [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => hay-fever-affects-sleep-relationships-and-careers-so-why-dont-sufferers-seek-help [to_ping] => [pinged] => [post_modified] => 2018-11-06 08:26:47 [post_modified_gmt] => 2018-11-05 22:26:47 [post_content_filtered] => [post_parent] => 0 [guid] => /www.australianpharmacist.com.au/?p=2983 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [title_attribute] => Hay fever affects sleep, relationships and careers â so why donât sufferers seek help? [title] => Hay fever affects sleep, relationships and careers â so why donât sufferers seek help? [href] => /www.australianpharmacist.com.au/hay-fever-affects-sleep-relationships-and-careers-so-why-dont-sufferers-seek-help/ [module_atts:td_module:private] => Array ( ) [td_review:protected] => Array ( ) [is_review:protected] => [post_thumb_id:protected] => 2986 )
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 2806 [post_author] => 27 [post_date] => 2018-10-01 13:30:59 [post_date_gmt] => 2018-10-01 03:30:59 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]Lithium is an invaluable and lifesaving treatment for a range of psychiatric disorders, but its origins lie in patent medicine and the pioneering work of an Australian doctor. People have been flocking to hot springs of lithium-heavy water for their perceived health benefits for millennia, but it was not until the second half of the 19th century that modern medicine put the element to use. In 1859, an English physician described the use of lithium carbonate to treat gout by solubilising uric acid in the blood, as well as treating âbrain goutâ, or mental upset. Over the next few decades, some US and Danish doctors reported that lithium carbonate could calm patients with âgeneral nervousnessâ, mania or depression.1 However, its use in medicine remained rare, with most use instead in food products. Until 1950, popular soft drink 7-Up2 contained lithium citrate and even beer3 was brewed with lithium-heavy water and promoted for its mood-enhancing abilities. However, both the real and perceived health benefits of lithium were overshadowed when lithium was prescribed to patients with heart disease as a replacement for salt.4 The resulting overdoses and deaths led to the US banning lithium as an additive in 1950. Elemental reactions The exact action of lithium to manage mood remains unclear, though it is clear the molecule acts on the brain on multiple levels. It offers neuroprotective and neuroproliferative effects on brain structure, as well as plasticity.5 It also modulates neurotransmission, inhibiting excitatory neurotransmitters such as dopamine and glutamate,6 and promoting GABA-mediated neurotransmission.6 In 1949 in a Melbourne mental hospital for World War II veterans, Dr John Cade theorised the mania he witnessed in his patients might be linked to the high levels of uric acid he detected in their urine, in line with the 19th century theories about gout. He experimented with injecting the urine collected from patients demonstrating mania into guinea pigs, which subsequently showed signs of agitation.1 Guinea pigs that were subsequently administered lithium following the urine injections rapidly calmed. Dr Cade then experimented on himself and when he showed no ill effects after a dose of lithium, he started a trial on 10 patients.7 His trial showed significant positive results, but a mixture of poor timing (given lithiumâs then-recent banning from food) and the then-obscurity of the Medical Journal of Australia where his article was published meant little acknowledgment.Â¹ Instead, Danish research published in 1954 detailing the results of a randomised trial kick-started lithiumâs renaissance.1 By 1970, lithium had been widely approved for treating bipolar disorder and other mental health issues.1 Thinking big In recent years, some studies have found a correlation between high levels of naturally occurring lithium in tap water and lower rates of suicide and mental health problems.2 However, these studies have had many limitations and there is no reliable evidence that says lithium addition to water or food would provide any health benefits.5 References
[/vc_column_text][/vc_column][vc_column width="1/3"][/vc_column][/vc_row] [post_title] => The story of lithium and mental health [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => the-story-of-lithium-and-mental-health [to_ping] => [pinged] => [post_modified] => 2018-10-03 14:18:15 [post_modified_gmt] => 2018-10-03 04:18:15 [post_content_filtered] => [post_parent] => 0 [guid] => /www.australianpharmacist.com.au/?p=2806 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [title_attribute] => The story of lithium and mental health [title] => The story of lithium and mental health [href] => /www.australianpharmacist.com.au/the-story-of-lithium-and-mental-health/ [module_atts:td_module:private] => Array ( ) [td_review:protected] => Array ( ) [is_review:protected] => [post_thumb_id:protected] => 2811 )
- Shorter E. The History of Lithium Therapy. Bipolar Disorders. 2009;11.
- Fels A. Should We All Take A Bit of Lithium? The New York Times. 2014 September 13. At: /www.nytimes.com/2014/09/14/opinion/sunday/should-we-all-take-a-bit-of-lithium.html?_r=0.
- Shepherd R. Lithia Beer returns to West Bend, expands across Wisconsin. Isthmus. At: /isthmus.com/food-drink/beer/lithia-beer-returns-to-west-bend-expands-across-wisconsin/.
- Hardman JG. Limbird PB. Gilman AG. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th Ed. New York. McGraw-Hill. 2001:507.
- Sachdev P. Letâs not put lithium in the drinking water just yet. Medical Republic. 2017 November 21. At: /medicalrepublic.com.au/lets-not-put-lithium-drinking-water-just-yet/11998.
- Brunton L. Chabner B. Knollman B. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th Ed. New York. McGraw-Hill. 2010:445.
- Mitchell PB. Hadzi-Pavlovic D. Lithium treatment for bipolar disorder. [Reproduced from The Medical Journal of Australia]. Bulletin of the World Health Organization, 2000;78(4):515.
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 2425 [post_author] => 12 [post_date] => 2018-08-22 08:45:22 [post_date_gmt] => 2018-08-21 22:45:22 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]With community pharmacies feeling the squeeze, there has never been a more important time to provide continuity of care by building patient loyalty. Self-serve checkouts, online stores and banking through phone apps: these days thereâs often little need to talk to a person when making day-to-day purchases or transactions. Pharmacy, however, remains one of the last bastions of good olâ fashioned human connection. âPatients are looking for connection,â said Capital Chemistâs Elise Apolloni MPS. âSo often when people engage with services or businesses thereâs nothing magical about the interaction.â Fortunately, pharmacists can use these increasingly rare personal interactions to provide patient-centred service and foster continuity of care, bringing positive patient outcomes. What customers want The strength of a patientâs loyalty is primarily driven by the behaviour of the pharmacist treating them â not the price of the medication or the location of the pharmacy. And thereâs no shortage of studies that reach this conclusion. A 2013 GriÂffith University study found that patient-centred care, such as providing individualised medication counselling, continuity of care, development of relationships and respectful advice, emerged as the most important attribute when it came to retention of regular community pharmacy users. Additionally, a US study published in the Journal of the American Pharmacists Association found that a pharmacistâs patient-centred communication style had a major influence on whether a patient would return to the pharmacy. Associate Professor in Marketing at the QUT Business School Dr Gary Mortimer said while many customers seek pharmacies with lower prices, consumers are turning to pharmacy for healthcare solutions and triage prior to consulting their GP. âWe see this mostly in consumers seeking access to flu jabs and health check-ups, possibly as a result of patients looking to avoid the high costs of seeing a GP for minor healthcare matters,â said Dr Mortimer, who is currently working on the research topic âClinical trials or pharmacist advice: The influence on health consumersâ perceptions of trust and decision makingâ. PSA NSW Branch Vice President Krysti-Lee Rigby MPS said that consumers also wanted value. But that does not necessarily mean being the cheapest. âValue can come from having engaged and competent staff, service that meets or exceeds expectations, the pharmacist being accessible, being able to trust their pharmacist, and of course convenience,â Ms Rigby said. Holistic care beneÂfits for patients The relationship between pharmacist and patient should not be the transactional kind of relationship you have at your local convenience store, Dr Mortimer said. âBetter patient healthcare outcomes result from ongoing, regular contact based on continuity of service and advice,â he said. Ms Apolloni said this was particularly apparent in the chronic disease space, where often a one visit solution wasnât possible. âIf a patient is not dazzled by your pharmacy and team, they may not return and youâve missed an opportunity to build a therapeutic relationship with that person and contribute positively to their healthcare,â Ms Apolloni said. âWeâve laughed with patients â and cried with them. I canât see how that kind of connection and holistic care can be anything but great for the patient, the job satisfaction of the pharmacist, and the wider healthcare system.â Ms Rigby added: âBy building trust with patients, we can increase compliance of medications, create better health outcomes by educating patients on how to better manage their medications, and empower patients to take a proactive approach to their health.â Ensuring continuity of care Dr Mortimer suggests pharmacies take a five-stage approach to maximising holistic care opportunities, starting with establishing integrity. âPharmacy must consistently deliver open and honest information across all touch points with consumers. Integrity cultivates trust between the patient and the pharmacy retailer,â he said. Pharmacists and assistants then need to provide expert advice around purchasing decisions. âConsumers have access to significant amounts of information today,â Dr Mortimer said. âIf a pharmacy assistant delivers inaccurate advice, or ill-informed advice that is not consistent, the patient-pharmacist trust relationship is damaged.â The third ingredient for maximising holistic care opportunities is ensuring the security of personal data, said Dr Mortimer. And fourth, pharmacies need to demonstrate competence. âTrust and continuity of care decrease when the consumer perceives that the pharmacy is incompetent in its dealings with them,â he said. âFor example, if the pharmacy is unable to perform transactions eÂfficiently, loses prescriptions, has poor service, fails to offer a lower-priced generic alternatives, or fails to keep promises.â Finally, and most importantly, said Dr Mortimer, the pharmacy must exhibit benevolence. âWhen a pharmacy demonstrates or promotes actions that indicate the support of the welfare of others over financial outcomes, consumers develop stronger levels of trust,â Dr Mortimer said. âBenevolence is diÂ cult to cultivate, as benevolent acts must be purely altruistic.â Ms Apolloni added that being genuinely present and interested in a patient was another important precondition for holistic care. âWe have many competing priorities, but it takes very little extra time to really listen and repeat back key pieces of information,â she said. Digital solutions One way pharmacists can deliver more holistic care and maximise time with patients is by harnessing the power of technology. Robert Read is CEO of MedAdvisor, a mobile and web app that manages all aspects of prescription medication use. One of the advantages of this type of digital solution, said Mr Read, was that it prompted patients when it was time to re-order their medication. âAnd 50% of orders from the app go into the pharmacy outside of business hours,â he said. âA pharmacy can then process those scripts before the doors even open so that when the patient comes in they can spend quality time counselling them.â âItâs really busy at the dispensary and pharmacists are doing all this processing work and not spending time talking to the patient about all the various things they might be eligible for,â Mr Read said. âWhat MedAdvisor does is identify all the eligible consumers, and then helps you invite them to services theyâre eligible for.â Mr Read said their research showed more than 90% of patients stayed loyal to the pharmacy that signed them up to the app. âNot only does it play a big role in driving loyalty, but it improves a patientâs adherence to their medication,â he said. Another way pharmacists are spending more time in front of patients is by purchasing an automated dispensing cabinet. Pharmacy owner and technology consultant Robert Sztar MPS said the cabinets could free up your staff to deliver high-quality services, while the dispenser tackles the more routine tasks. Avoiding poor patient service Making patients aware of additional services theyâre eligible for is an important part of providing holistic care, but Dr Mortimer said pharmacists need to be aware that not all up-sells are appreciated â especially product-based ones. âIt frustrates consumers. Theyâll pop in to collect a prescription and be up-sold OTC products, cosmetics or skincare products,â he said. âWhile revenue and the bottom line is important, pushing sales is a short-term solution. If a consumer genuinely feels a pharmacy is taking the time to get to know them, really understanding their needs to develop healthcare solutions, they will keep coming back.â Take a stand While consumers do not necessarily become loyal to a particular brand or pharmacy, they do become loyal to what the business stands for, Ms Rigby suggested. âFor community pharmacies to continue to be viable, they need to have clear missions and values, and ensure their staff align with them,â she said. âPharmacies need to show consumers what they stand for, besides making money.â
|Ways to foster patient loyalty
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 2442 [post_author] => 66 [post_date] => 2018-08-07 11:45:10 [post_date_gmt] => 2018-08-07 01:45:10 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]A group of Melbourne pharmacists have developed a data aggregation and visualisation platform used for strengthening health supply chains, disaster response and improving health services throughout the South Pacific. In June, the project won the Peopleâs Prize at the the Australian Public Service Innovation Awards in Canberra. The tool builds a map of every health facility within the countries that are participating in the project. Currently, six countries have partnered (Solomon Islands, Vanuatu, Kiribati, Cook Islands, Tokelau and Tonga) and that number is expected to grow further in 2018, with potential applications for Australia. âKiribati has seen a 21% increase in the availability of medicines at the primary healthcare level since September 2017, which is a terrific result in a difficult geographic area,â project member Kahlinda Mahoney said. The project is named after Tupaia, a legendary Pacific Island navigator who joined Captain Cookâs crew as he sailed through Tahiti in 1769. Using an app called Tupaia MediTrak to collect information from public health facilities, the tool syncs this information with data pulled from the pharmacy software used in each country â mSupply, used in about 30 countries around the world. Tupaia also pulls data from the software used for disease tracking in many countries in the region (using open-source health information software DHIS2) and it presents this information in preconfigured dashboards and map overlays on a public website. Password-enabled access allows higher-level users to see more data but the public can see the location of facilities, the services they provide and their opening hours. So far, the project has mapped all 600 facilities across the six partner countries. âTupaia can be used for a huge range of programs. For example, it provides a map of the fridges in all the health clinics in Solomon Islands, showing whether they are working or not. This can be used by the national cold chain manager there to help plan their annual maintenance schedule,â mapping team lead Susie Lake said. âThe EPI program manager in Vanuatu might use it to map the availability of vaccines and pregnant mums might look up the location of the nearest facility that can handle emergency obstetric situations.â The project is strongly focused on improving access to essential medicines. In Kiribati, Tupaia worked in partnership with mSupply to roll-out a mobile version of the widely used pharmacy software. Ms Mahoney said the current version of mSupply Mobile was launched in 2016 and Australiaâs Department of Foreign Affairs and Trade (DFAT) paid for it to be released âopen-sourceâ in 2017. âThis meant countries were able to roll it out more quickly and more widely than was possible before, as there are no longer licensing fees attached to it,â she said. âWe started this project to strengthen health supply chains in the Pacific, to make sure that medicines were getting to the right people at the right time â but it has grown to include disaster response, disease tracking, infrastructure, HR â itâs exciting but weâre always keen to do more,â Ms Lake said. âThere may be application here in Australia, particularly with recent commentary and events around medicines and vaccine stock-outs but weâll just have to wait and see.â Now 12 months old, the Tupaia project has been funded by the innovationXchange, part of the aid program at Australiaâs DFAT. The focus on essential medicines in the region comes at a time when antimicrobial resistance, counterfeit medicines and medicines shortages are being recognised as serious regional health threats. [/vc_column_text][/vc_column][vc_column width="1/3"][/vc_column][/vc_row] [post_title] => Navigating South Pacific health care on a sea of data [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => navigating-south-pacific-health-infrastructure-on-a-sea-of-data [to_ping] => [pinged] => [post_modified] => 2018-08-07 12:01:36 [post_modified_gmt] => 2018-08-07 02:01:36 [post_content_filtered] => [post_parent] => 0 [guid] => /www.australianpharmacist.com.au/?p=2442 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [title_attribute] => Navigating South Pacific health care on a sea of data [title] => Navigating South Pacific health care on a sea of data [href] => /www.australianpharmacist.com.au/navigating-south-pacific-health-infrastructure-on-a-sea-of-data/ [module_atts:td_module:private] => Array ( ) [td_review:protected] => Array ( [td_primary_cat] => 26 [smart_list_template] => td_smart_list_5 ) [is_review:protected] => [post_thumb_id:protected] => 2443 )
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 2191 [post_author] => 2 [post_date] => 2018-07-28 14:00:30 [post_date_gmt] => 2018-07-28 04:00:30 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]Pharmacist-led health interventions in Aboriginal communities came under the spotlight at PSA18 in Sydney yesterday, as delegates got early insight into some of the Pharmacy Trial Program (PTP) studies currently underway. The 6CPA allocated $50 million to fund the program, aimed at gathering evidence to expand the role of pharmacy in delivering a wider range of primary healthcare services, with a particular focus on Aboriginal and Torres Strait Islander populations. One trial currently in start-up is the Indigenous Medication Review Service Feasibility Study (IMeRSe), led by Griffith Universityâs Professor Amanda Wheeler. âThe overall goal is to improve medication management and health and wellbeing for Aboriginal and Torres Strait Islander people through strengths-based collaborative and culturally appropriate pharmacy service,â she said. âWe know that medication reviews are funded but the research told us that for Indigenous people they have problems accessing medication reviews for many reasons. One of those is that talking to a pharmacist at a pharmacy or in their own home may not be a culturally safe space.â âThat review service doesnât involve anyone from the Aboriginal Health Service (AHS) â their trusted person who they work with and knows them so well. Only a GP may refer someone for a Home Medicines Review and that process may take several weeks. âThey also tend to be a one-off and there is no ability for the pharmacist to check in in a funded way and see how things are going or tackle complex problems over a few months. There is also a lack of integration between pharmacists and Aboriginal Health Services.â IMeRSe will involve up to 23 pharmacies across Queensland, the Northern Territory and New South Wales, and up to 540 AHS patients. âItâs a pharmacy service to promote health and wellbeing by optimising an individualâs medication management through a culturally responsive medication review service,â Prof Wheeler said. âIt will be delivered by community pharmacists but they are going to be integrated with Aboriginal Health Services as part of holistic care. We want to enhance existing services.â With seven patients already recruited, the project is already gathering positive feedback, including from involved GPs.[/vc_column_text][/vc_column][vc_column width="1/3"][/vc_column][/vc_row] [post_title] => Greater pharmacist role in Aboriginal health trialled [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => trials-lead-the-way-for-greater-pharmacist-role-in-aboriginal-health [to_ping] => [pinged] => [post_modified] => 2018-07-28 14:01:52 [post_modified_gmt] => 2018-07-28 04:01:52 [post_content_filtered] => [post_parent] => 0 [guid] => /www.australianpharmacist.com.au/?p=2191 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [title_attribute] => Greater pharmacist role in Aboriginal health trialled [title] => Greater pharmacist role in Aboriginal health trialled [href] => /www.australianpharmacist.com.au/trials-lead-the-way-for-greater-pharmacist-role-in-aboriginal-health/ [module_atts:td_module:private] => Array ( ) [td_review:protected] => Array ( [td_primary_cat] => 21 ) [is_review:protected] => [post_thumb_id:protected] => 2256 )
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 2187 [post_author] => 2 [post_date] => 2018-07-27 13:58:55 [post_date_gmt] => 2018-07-27 03:58:55 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]The rise in patient access to information about managing their own health should not threaten to supplant pharmacists but instead make them more essential than ever, according to International Pharmaceutical Federation (FIP) CEO Dr Catherine Duggan. Helping open PSA18 in Sydney yesterday, Dr Duggan said pharmacists should take a leading role in helping healthcare transition to being digitally led. 'Where we find ourselves now is not in the Industrial Age but in the Information Age and that puts us into a position where patients seem to be empowered and have access to more and more relevant information at their fingertips through, for example, Dr Google,â she said. 'Patients and consumers have greater education, knowledge and power â or more access to education, knowledge and power â and can put us into tricky situations. Do we need pharmacists any more? Do we need pharmacists as we used to be? Those are the questions that many fear in our profession. 'The answer is never more. Ever more medicines are being taken by ever more frail and elderly patients in a society where we are growing more resistant to the antimicrobials we know and trust. Never more have we needed pharmacists and pharmaceutical scientists to be the solution-makers of our future.' Dr Duggan said pharmacists needed to be empowered, enabled and emboldened to be the custodians of their patientsâ medicines. 'We need to empower our patients and the public to be able to look after themselves while well and to look after themselves while frail, and we need to be the stewards and the custodians of the medicines they are prescribed,â she said. Dr Duggan also highlighted the vast gulf in access to pharmacy services between low- and high-income countries, with FIP research finding just one pharmacist per 20,000 people in many low-income countries, a figure more than 13 times lower than that of high-income countries. 'It is the level of inequity that should cause us concern,â she said. 'What should concern is that not every patient has access to the pharmacist care they need.'[/vc_column_text][/vc_column][vc_column width="1/3"][/vc_column][/vc_row] [post_title] => Pharmacists must be 'empowered and emboldened' in the new digital age [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => dr-catherine-duggan-talks-innovation-in-pharmacy [to_ping] => [pinged] => [post_modified] => 2018-07-28 13:53:26 [post_modified_gmt] => 2018-07-28 03:53:26 [post_content_filtered] => [post_parent] => 0 [guid] => /www.australianpharmacist.com.au/?p=2187 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [title_attribute] => Pharmacists must be ’empowered and emboldened’ in the new digital age [title] => Pharmacists must be ’empowered and emboldened’ in the new digital age [href] => /www.australianpharmacist.com.au/dr-catherine-duggan-talks-innovation-in-pharmacy/ [module_atts:td_module:private] => Array ( ) [td_review:protected] => Array ( [td_primary_cat] => 26 ) [is_review:protected] => [post_thumb_id:protected] => 2251 )
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 2996 [post_author] => 11 [post_date] => 2018-11-08 09:04:04 [post_date_gmt] => 2018-11-07 23:04:04 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]Male pharmacy graduates earn an average $10,000 more than their female counterparts after three years on the job, a new report has shown. Although female graduates start their careers earning ever-so-slightly more than men ($200 a year more), after three years male pharmacists earn an average 12% more, according to the recently released 505-738-4882. General Manager at Raven's Recruitment Heidi Dariz says the $10,000 disparity is disappointing. 'On the one hand I find it a little surprising since pharmacy is an industry that employs more women than men,' she says. 'However, it's also unsurprising in that there are definitely more male pharmacists working in higher-paying managerial roles a lot sooner than females.' The Quality Indicators for Learning and Teaching report suggests that the gender pay gap cannot be attributed to the employment status â three years after graduating 93.4% of female graduates were in full-time employment versus 92.1% of men. Instead, Ms Dariz suggests that male pharmacists' higher confidence levels may lead to better pay outcomes. 'We find that we have male pharmacists feeling confident in applying for management roles as soon as they finish their internship, when generally women would want a few years experience working as a team pharmacist before taking this step,' Ms Dariz says. 'Also, men are typically more confident and happy to ask their current employers for a pay rise than women, leading to a discrepancy in wages.' Ms Dariz says that shared parental leave and affordable child care could go a long way towards closing the pay gap. 'I don't think enough is being done in this area at present in pharmacy unfortunately,' she says. The findings are in line with previous Australian and international trends. In 2016, analysis of ATO and ABS data showed that male pharmacists earned an average $85,362 a year while women earned more than $20,000 less at $63,503 a year. When adjusted for hours worked, there was still a 14% gender pay gap. Research shows that in the UK the gap is 12.6%, while in the US women pharmacists make 82 cents to the dollar men earn doing the same job. Ms Dariz says there are reasons for optimism in Australia however. 'I know that many pharmacy employers and groups are offering mentoring programs for women in pharmacy â promoting female entrepreneurship and ownership â which will go a long way in closing this gap,' she says. 'Also, we are currently experiencing pharmacist shortages in community pharmacy, which has led to an overall increase in pharmacist wages in the past 12 months. 'I believe the gap will lessen as more women enter the pharmacy industry and will take on these managerial roles earlier, due to current skill shortages.' [/vc_column_text][/vc_column][vc_column width="1/3"][/vc_column][/vc_row] [post_title] => $10,000 gender pay gap between early career pharmacists [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => 10000-gender-pay-gap-between-early-career-pharmacists [to_ping] => [pinged] => [post_modified] => 2018-11-08 09:05:06 [post_modified_gmt] => 2018-11-07 23:05:06 [post_content_filtered] => [post_parent] => 0 [guid] => /www.australianpharmacist.com.au/?p=2996 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [title_attribute] => $10,000 gender pay gap between early career pharmacists [title] => $10,000 gender pay gap between early career pharmacists [href] => /www.australianpharmacist.com.au/10000-gender-pay-gap-between-early-career-pharmacists/ [module_atts:td_module:private] => Array ( ) [td_review:protected] => Array ( ) [is_review:protected] => [post_thumb_id:protected] => 2997 )
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 2980 [post_author] => 11 [post_date] => 2018-11-05 14:23:40 [post_date_gmt] => 2018-11-05 04:23:40 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]Dr Renly Lim is a Research Fellow at the University of South Australia working to expand the role of pharmacists in residential care facilities, developing and evaluating a service to prevent medication-related side effects using digital health tools. How did your National Health and Medical Research Council project come into being? Iâve not worked in residential care facilities (RCFs) but I volunteer just as someone whoÂ is keen on helping older people. When the residents found out I was a pharmacist I started hearing stories from them saying, âIâm convinced that ever since the doctor gave me this medicine Iâm losing my balance.â It seemed that if they said this to the nurses theyâd be told, âOh no, youâre fine. You just sit down there and weâll talk to the doctor.â But that seemed to never happen and the resident wouldnât get the opportunity to see their pharmacist. I thought, âWhat if they do have a fall?â Iâd feel responsible for not doing anything. So that made me feel that there is so much more that we can do for people in RCFs. The project came into conception when I started working with Professor Libby Roughead at the Quality Use of Medicines and Pharmacy Research Centre. Together with other co-investigators, we prepared a grant for the Pharmacy Trial Program. So how does your NHMRC project help address that? The overarching theme is digital health and medication safety. The most exciting objective is to develop and evaluate a novel pharmacy service in a randomised controlled trial in order to identify and prevent medication-related side effects in older people. Weâve already started the participatory action research phase â weâll be asking pharmacists to use a range of tools and weâve started teaching them how to use them. Weâre going to ask to fit an activity tracker on the residents, measure changes in weight and grip strength and other indicators of medication-induced side effects. The pharmacists will then review the residential aged-care assessment records, interview patients, make recommendations to the residentsâ GPs, and follow up on residentsâ conditions during the next sessional pharmacist visit. How could your work help change the role of pharmacists? Currently the role of pharmacists in RCFs is quite limited â most of their work is Residential Medication Management Reviews. In this clinical trial we are testing a pharmacy session every eight weeks over a year. The trial is funded by the federal Department of Healthâs Pharmacy Trial,Â and the service will be evaluated by the Medical Services Advisory Committee to determine if it is effective and cost-effective. If itâs successful, we hope that the program will be implemented nationally. That would greatly expand the nature of services that pharmacists can provide in RCFs. During all this, you were involved in a University of Oxford project called Village Drama Against Malaria (VDAM). Tell us about your work in Cambodia? The project was a science-art innovation involving a series of two-and-a-half day workshops, followed by a drama performance in each village. The three key messages of the drama project were the need to use insecticide-treated bed nets and repellents, the importance of early diagnosis and treatment, and the risks of malaria. We saw very positive response in the villages. I led the evaluation to assess the feasibility of using drama as a community engagement strategy for malaria elimination. We found that drama was effective in promoting awareness and understanding of malaria elimination. Getting involved in this project was one of the most rewarding experiences in my career thus far. I got to know many international researchers, some of whom have become my research collaborators. Most importantly, Associate Professor Phaik Yeong Cheah from University of Oxford, and the head of the VDAM project, is now my mentor for my NHMRC fellowship. What was the highlight of that experience for you? It was a huge culture shock. When they asked if Iâd like to be involved I said yes without knowing what I signed up for. The project was in a really remote area of Cambodia, where people have really limited access to education and health services. Thereâs a general lack of infrastructure, the roads are in terrible condition and they donât have access to clean water. Now, I know that Denmark and Norway got voted as the happiest countries in the world, but I feel like the Cambodian people are genuinely the happiest people in the world. They have so little, yet theyâre really happy about living. So now every time Iâm stressed about research I remember my time in Cambodia â when I taught them about malaria and they taught me about life. Â Â Â Â Â [/vc_column_text][/vc_column][vc_column width="1/3"][/vc_column][/vc_row] [post_title] => Pharmacist Insight â Older and Wiser [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => pharmacist-insight-older-and-wiser [to_ping] => [pinged] => [post_modified] => 2018-11-05 14:24:03 [post_modified_gmt] => 2018-11-05 04:24:03 [post_content_filtered] => [post_parent] => 0 [guid] => /www.australianpharmacist.com.au/?p=2980 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [title_attribute] => Pharmacist Insight â Older and Wiser [title] => Pharmacist Insight â Older and Wiser [href] => /www.australianpharmacist.com.au/pharmacist-insight-older-and-wiser/ [module_atts:td_module:private] => Array ( ) [td_review:protected] => Array ( ) [is_review:protected] => [post_thumb_id:protected] => 2981 )
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 2706 [post_author] => 11 [post_date] => 2018-09-17 10:00:16 [post_date_gmt] => 2018-09-17 00:00:16 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]Geraldine Moses FPS wears many hats. Sheâs a hospital-based drug information consultant and clinical pharmacist, and provider of the Australian Dental Associationâs (ADA) national drug information advisory service, Pharma-Advice. Dr Moses is also an adjunct associate professor at the University of Queensland and co-founder of medicines education service, Pharmeducation, among many other things. Many young pharmacists are unsure of how to build their careers. How have you carved out such a unique and successful path? The two main things that have driven my career are building relationships and accepting new opportunities when they come along. For example, back in the 1990s I knew some people who worked on ABC radio. One day the doctor who hosted the medical talkback show didnât turn up so they asked me to do it instead. I anxiously accepted and ended up doing a medication-based talkback show for 15 years. The Queensland medication helpline and NPS MedicineWise lines we operated at the Mater grew from that radio work â after every talkback segment Iâd be back working in ICU at the hospital and weâd get calls from people saying âI want to talk to the girl on the radioâ. And another driver was being really good at what you do? Donât just think âIâm pretty goodâ, be very good. And donât rely solely on what you learned at university. To be an exceptional pharmacist you must constantly study. I find many pharmacists today donât go back to first principles or memorise facts because they think you can Google it. Obviously anybody can Google things so itâs imperative, if you want to be an expert or consultant, to have extensive knowledge thatâs better than Google. With the surname Moses I often joke about commandments. Commandment Number One of Medicines Information is: always consult more than one source, and not just the internet. Another common thread seems that youâve been prepared to take risks, and be somewhat entrepreneurial? I learned pretty early that if you want to do new and interesting things you have to be brave. My advice for people who are aspiring to become a consultant or branch out into new areas of pharmacy is: have courage to grab opportunities and run with them intelligently. My work with ADA, for example, started because I knew a dentist who asked me to present a lecture for his study group. I had no idea what they wanted me to talk about, but I followed the rule about telling them something they donât know. I chose drug interactions, and it worked. That study group led to others, which eventually led to working with ADA Queensland. The state president came up with the idea of starting their own drug information service, which eventually was adopted nationally. What other commandments or advice do you have for pharmacists looking to make their mark? There are many professions out there that need our help. Nurse practitioners, optometry, podiatry, physiotherapy â theyâre all prescribing drugs and would benefit from an expert pharmacist. Initially you may have to offer your services for free but once they get to know you and realise the value of your contribution, the money will come.[/vc_column_text][/vc_column][vc_column width="1/3"][/vc_column][/vc_row] [post_title] => Carving one's own path as a consultant pharmacist [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => commanding-moses-consultant-pharmacist [to_ping] => [pinged] => [post_modified] => 2018-09-18 15:45:08 [post_modified_gmt] => 2018-09-18 05:45:08 [post_content_filtered] => [post_parent] => 0 [guid] => /www.australianpharmacist.com.au/?p=2706 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [title_attribute] => Carving one’s own path as a consultant pharmacist [title] => Carving one’s own path as a consultant pharmacist [href] => /www.australianpharmacist.com.au/commanding-moses-consultant-pharmacist/ [module_atts:td_module:private] => Array ( ) [td_review:protected] => Array ( ) [is_review:protected] => [post_thumb_id:protected] => 2707 )
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 2639 [post_author] => 40 [post_date] => 2018-09-05 11:46:53 [post_date_gmt] => 2018-09-05 01:46:53 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]Australian pharmacy professionals have received top honours at the 78th FIP World Congress of Pharmacy and Pharmaceutical Sciences in Glasgow, while PSA has been named co-host for the FIP Congress in 2021. PSA members Tina Brock MPS and John Bell FPS were awarded Fellowship of the International Pharmaceutical Federation (FIP) at the conference, reflecting their years of dedication to the profession at academic, executive and career development levels. Dr Brock is the Professor of Pharmacy Education and Practice in the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University. She has had an international career in pharmacy leadership curriculum design in academic institutions including University of California San Francisco, University of London and University of North Carolina at Chapel Hill. Mr Bell served as the NSW and National PSA President and now works as a community pharmacist in Sydney and specialist practitioner/teacher in primary health care at the Graduate School of Health, University of Technology Sydney. Â He is a PSA NSW Branch Committee Member and sits on the boards of Diabetes NSW/ACT and the Australian MedicAlert Foundation, and is a member of the Global Respiratory Infection Partnership, an international multidisciplinary group established to address antibiotic resistance. PSA National President Dr Shane Jackson said he was delighted to hear of Mr Bellâs achievement. âJohn has worked tirelessly for the profession both in Australia and on the international stage, from highlighting the role of pharmacists in our healthcare system to delivering continuing education and mentoring Early Career Pharmacists,â he said. âItâs hard to overstate the extent of his ongoing contribution not only to PSA but to the practice ofÂ pharmacy in Australia and overseas.â Mr Bell said he was humbled by the recognition. âI feel honoured to have joined an eminent group of Australian pharmacists who have been similarly honoured by FIP,â Mr Bell said. âItâs been a privilege to have represented FIP as a vice president for eight years and also to have worked internationally with the Commonwealth Pharmacists Association, especially in the areas of pharmacist management of TB, malaria and HIV/AIDS.â Mr Bell received the honour in recognition of his strong international leadership, contribution to the advancement of the practice of pharmacy and service to FIP. The 2018 Andre Bedat medal, FIPâs highest pharmaceutical practice award, was awarded to Emeritus Professor Lloyd Sansom FPS from the Australian Pharmacy Council. With a distinguished career in education, research and policy, Prof Sansom has advised the Australian Government and World Health Organisation on pharmaceutical policy. Dr Jackson said Prof Sansom was recognised nationally and internationally as a visionary leader of the profession, and as one of pharmacyâs âleading lightsâ. âLloyd is a tireless advocate for the role of pharmacists in the healthcare system and we can trace a large number of activities and services that pharmacists deliver now to the leadership shown by Lloyd,â he said. âOver more than five decades he has had a huge influence on the quality use of medicines in Australia, contributing to almost all aspects of pharmacy practice, from research and education to leadership and policy.â The FIP conference also saw the election of Swiss pharmacist Dominique Jordan as president of FIP. Mr Jordan, a community pharmacy owner and former chief executive officer of the Swiss Association of Pharmacists (pharmaSuisse), has served FIP for over a decade including as chair of the federationâs Board of Pharmaceutical Practice since 2014. As a president of pharmaSuisse for 12 years, Mr Jordan led advances in the pharmacy profession in Switzerland, which included the introduction of a postgraduate title for hospital and community pharmacists, the introduction of a number of remunerated new pharmacy services and the implementation of an International Organisation for Standardisation compatible quality management system, allowing the evaluation of pharmacies. Meanwhile, Australia has been announced as the host for the 2021 FIP World Congress of Pharmacy and Pharmaceutical Sciences, with Brisbane to play host city. PSA, in collaboration with the Society of Hospital Pharmacists of Australia and the Australasian Pharmaceutical Science Association won a consortium bid to host the major international event at the Brisbane Convention & Exhibition Centre. Combined, the host organisations represent over 20,000 members across Australia in community and hospital pharmacy, academia and the pharmaceutical sciences.[/vc_column_text][/vc_column][vc_column width="1/3"][/vc_column][/vc_row] [post_title] => Australia excels on the global pharmacy stage [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => australia-excels-on-the-global-pharmacy-stage [to_ping] => [pinged] => [post_modified] => 2018-09-05 14:08:29 [post_modified_gmt] => 2018-09-05 04:08:29 [post_content_filtered] => [post_parent] => 0 [guid] => /www.australianpharmacist.com.au/?p=2639 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [title_attribute] => Australia excels on the global pharmacy stage [title] => Australia excels on the global pharmacy stage [href] => /www.australianpharmacist.com.au/australia-excels-on-the-global-pharmacy-stage/ [module_atts:td_module:private] => Array ( ) [td_review:protected] => Array ( [td_primary_cat] => 21 ) [is_review:protected] => [post_thumb_id:protected] => 2643 )
td_module_mega_menu Object ( [authorType] => [post] => WP_Post Object ( [ID] => 2372 [post_author] => 12 [post_date] => 2018-08-30 13:45:51 [post_date_gmt] => 2018-08-30 03:45:51 [post_content] => [vc_row][vc_column width="2/3"][vc_column_text]Isolation, recruiting staff and juggling a whole lot of balls at once are key challenges facing rural pharmacists. Rural pharmacy owner Courtney McMahon MPS talks about the challenges and the rewards. How did you become a rural pharmacy owner in Biloela, central Queensland? Biloela is my hometown and I was lucky enough to be taken on as a junior back when I was about 15. I continued to work there during school and university holidays under two great mentors, Shane Britnell and Naomi Bath. Naomi and I remained in contact and in 2016 she approached me and asked if I would be interested in moving from Noosa back to Biloela and buying into the business. What are some of the biggest challenges you face? Staffing can be a real challenge â you have limited options with a smaller population. Lack of access to doctors and specialists can also be really challenging. But there are so many great aspects to working in a rural area, other than a more attractive salary, that are often overlooked by pharmacists: more agreeable working hours, extremely short commutes to work and an altogether more relaxed lifestyle and work-life balance. What do you find most satisfying? It is extremely rewarding to know that, if every day I go to work and do the absolute best I can for my customers, it will directly aÂffect not only the business but also the community I serve in a positive way. We as pharmacists are really trusted healthcare professionals, but being an owner of a pharmacy in this small community means that people donât only trust me because Iâm a pharmacist, they trust me because they know me. For me the experiences that really stand out though are when family members come in and thank you after youâve assisted their loved ones. Anything you wish youâd known before embarking down this career pathway? It is essential to back yourself and surround yourself with people who support you wholeheartedly. There will always be those who make you question yourself from time to time. While it is important to be self-critical and examine your decisions, itâs equally as important to have confidence and belief in yourself. I am really lucky to have my family close by and a partner (who I actually met here in Biloela) who are so supportive of me and my goals. Further resources Join the PSA Mentoring Program to find a mentor to guide you on your career pathway. Visit (438) 288-0140 Â Â
A day in the life of Rural Pharmacy Owner Courtney McMahon MPS, Biloela Medical Centre Pharmacy and Biloela Discount Chemist5.30am: Morning workout If I get in any exercise for the day, this is when it happens! 6.30am: Prepare for the day Usually Iâll go over any emails or correspondence while I eat breakfast and prepare for the day ahead. 8.30am: The pharmacy opens The mornings are usually crazy so itâs mainly focussed on our professional role in dispensing and patient counselling etc. 9.30am: Collaboration Meetings with the nursing home and doctors when necessary. 10.30am to 2.00pm: Power through lunch Thereâs usually only one pharmacist (me) in the store, so I eat lunch on the run and deal with any Webster changes. 2.00pm: Reach out to the community We send out the daily nursing home delivery and any other deliveries. 2.30 to 3.00pm: Prep for tomorrow Ensure any orders we need for next-day delivery are in. 3.00 to 5.00pm: The after-school rush I also continue checking DAAs and make sure weâre up to date with banking, stock reporting and any other administrative jobs. 5.00 to 7.00pm: Stay on top of things If I have any work leftover Iâll stay and complete this after hours. If we have a staÂff meeting weâll also do this once we are closed. Explore new paths at 684-644-7573 [/vc_column_text][/vc_column][vc_column width="1/3"][/vc_column][/vc_row] [post_title] => Rural pharmacy owner [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => rural-pharmacy-owner [to_ping] => [pinged] => [post_modified] => 2018-08-30 10:26:20 [post_modified_gmt] => 2018-08-30 00:26:20 [post_content_filtered] => [post_parent] => 0 [guid] => /www.australianpharmacist.com.au/?p=2372 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [title_attribute] => Rural pharmacy owner [title] => Rural pharmacy owner [href] => /www.australianpharmacist.com.au/rural-pharmacy-owner/ [module_atts:td_module:private] => Array ( ) [td_review:protected] => Array ( [td_primary_cat] => 28 ) [is_review:protected] => [post_thumb_id:protected] => 2374 )
Get your weekly dose of the news and research you need to help advance your practice.